United States Dengue Vaccine Market Growth Driven by Global Vaccination Initiatives and High Disease Burden | Key Players: Sanofi, Panacea Biotec, Biological, E. Limited, GlaxoSmithKline plc, Merck & Co., Takeda Pharmaceutical Company Ltd

Dengue Vaccine Market size was valued at USD million in 2023 and is estimated to reach USD million by 2031, growing at a CAGR of 10.4% during the forecast period (2024-2031).

The most recent report published by DataM Intelligence indicates that the "Dengue Vaccine Market" is likely to accelerate significantly in the next few years. The Dengue Vaccine Market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The Dengue Vaccine Market study includes information on market factors such as the market dynamics, drivers, restraints, challenges, threats, potential growth opportunities, market trends, development patterns, financial information, latest technologies, innovations, leading competitors, and regional analysis of the market.

Dengue vaccines aim to protect against the dengue virus (four serotypes) and reduce severe disease; global demand is driven by endemic regions and travel. The market is evolving as new vaccine platforms and age-indication expansions progress. In the U.S., activity centers on travel-medicine guidance, clinical trial participation for improved formulations, and CDC/health authority communication on appropriate use for travelers and specific risk groups.

Download Latest Sample of This Strategic Report@ https://www.datamintelligence.com/download-sample/dengue-vaccine-market?ophp

The list of Key Players Profiled in the study includes:- Sanofi, Panacea Biotec, Biological, E. Limited, GlaxoSmithKline plc, Merck & Co., Takeda Pharmaceutical Company Ltd, Vabiotec, Panacea Biotec and Medigen Biologics.

United States: Recent Dengue Vaccine Developments

📌 In June 2025, Merck initiated the MOBILIZE-1 Phase 3 clinical trial for its single-dose dengue vaccine candidate, V181. The study aims to evaluate the vaccine's safety and efficacy in preventing dengue caused by all four serotypes in children aged 2-17 in dengue-endemic regions of Asia and the Pacific.

📌 In July 2025, the U.S. Centers for Disease Control and Prevention (CDC) reported a significant increase in locally transmitted dengue cases, with over 3,700 new infections and 105 confirmed locally acquired cases in Florida, California, and Texas. This surge underscores the growing public health concern and the need for effective vaccination strategies.

📌 As of September 2025, the U.S. Food and Drug Administration (FDA) has not yet approved QDENGA® (TAK-003), the only licensed dengue vaccine that can be used for individuals both with and without a previous dengue infection. However, the vaccine is authorized in over 30 countries and is under consideration for approval in the U.S.

Japan: Recent Dengue Vaccine Developments

📌 In June 2025, Japan's Ministry of Health, Labour and Welfare announced plans to incorporate QDENGA® (TAK-003) into the national immunization schedule for children aged 6-16 years in regions with high dengue transmission. This move aims to bolster the country's preventive measures against dengue outbreaks.

📌 As of September 2025, Japan continues to monitor and report on dengue cases among travelers returning from endemic countries. The government is actively promoting awareness campaigns and preventive measures to mitigate the risk of local transmission.

Competitive Analysis:

The Dengue Vaccine Market is expected to grow significantly over the forecast period between 2025 and 2032. In 2025, the Dengue Vaccine Market will grow steadily, and with the increasing adoption of strategies by the major players; the research study is expected to rise above the forecast horizon. The competitive analysis focuses on key players and the innovations and business strategies undertaken by them. The report captures the best long-term growth opportunities for the industry and includes the latest process and product developments.

Market Dynamics:

✅Driver: Increasing incidence of dengue worldwide and WHO recommendations drive vaccine demand.
✅Restraints: Limited vaccine efficacy and safety concerns restrain adoption.
✅Opportunities: Development of next-generation vaccines and regional immunization programs create potential.
✅Challenges: Regulatory hurdles and affordability in developing regions remain challenges.

Segmentation Analysis of the Market:

Global Dengue Vaccine Market forecast report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market. Dengue Vaccine Market, By Product Type (CYD-TDV), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others)

Research Methodology:

- Primary Research: This method involves collecting new and original data for a specific purpose. Primary research is often conducted through surveys, interviews, focus groups, and observation. It enables researchers to obtain first-hand information directly from the target audience, which is especially useful when researching a new or emerging market.

- Secondary Research: This method involves analyzing and synthesizing existing data from various sources such as industry reports, government publications, academic research, and online databases. Secondary research can provide researchers with valuable insights into industry trends, consumer behavior, and Dengue Vaccine market size and growth, without the need for extensive data collection.

Most research studies use a combination of both primary and secondary research methods to ensure comprehensive and accurate data analysis. The specific methodology used in a Dengue Vaccine market research study will depend on various factors such as the research objectives, the target audience, and the available resources.

Request Customized Market Entry Assessment for North America, EU, APAC: https://www.datamintelligence.com/customize/dengue-vaccine-market?ophp

Regional Outlook:

The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)

South America (Brazil, Argentina, Rest of SA)

Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

The analysis objectives of the report are:

- To determine the size of the Global Dengue Vaccine Market by identifying its sub-segments.

- To research the key players and analyze their growth strategies.

- To assess the size and value of the Global Dengue Vaccine Market based on key regions.

- To analyze the Global Dengue Vaccine Market in terms of growth trends, potential, and participation in the overall sector.

- To investigate the Global Dengue Vaccine Market size (volume and value) from the company, key regions/countries, goods and applications, and background data.

- Primary Global Dengue Vaccine Market manufacturers to specify, clarify, and analyze the product sales volume, value, and market share, market rivalry landscape, SWOT analysis, and future development plans.

- To investigate market competitive developments such as market expansions, agreements, new product launches, and acquisitions.

Reasons to buy:

- Dengue Vaccine Market Report segments the market based on economic and non-economic aspects and offers a qualitative and quantitative analysis of the market.

- Market value information is provided for each segment and sub-segment in the Dengue Vaccine Market study.

- The region and market segment identified in this study are those predicted to expand the fastest and account for the majority of market shar

- The Dengue Vaccine Market Analysis by Geography emphasizes the product or service's consumption in the area and identifies the market-affecting variables for each region.

- The major players' market rankings, as well as the recent partnerships, service/product launches, business expansions, and acquisitions of the companies profiled, are all included in the competitive landscape.

- Extensive company profiles for the top market players, including business overview, company insights, product benchmarking, and SWOT analysis.

- The industry's present and upcoming market outlook in consideration of recent changes, including growth possibilities and drivers as well as obstacles and restrictions in both developing and emerging regions.

- The Dengue Vaccine Market offers comprehensive market analysis from a variety of angles using Porter's five forces analysis, as well as market insight using the Value Chain.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=dengue-vaccine-market

The report answers a number of crucial questions, including:

- Which companies dominate the global Dengue Vaccine market?

- What current trends will influence the market over the next few years?

- What are the market's opportunities, obstacles, and driving forces?

- What predictions for the future can help with strategic decision-making?

- What advantages does market research offer businesses?

Get Corporate Access to Live Dengue Vaccine Industry Intelligence Database: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.